New presentation of Ursobilane

With the recent presentation of Ursobilane 500 mg, developed entirely in-house, Estedi completes the ursodeoxycholic acid family together with the doses of 150 and 300 mg. 60 capsules.

With this new dose we try to improve the quality of life of patients and continue to offer the best alternative for the treatment of hepatobiliary diseases.

Ursobilane, nueva presentación.

Ursobilane, nueva presentación.

Tagged with: